REXAHN PHARMACEUTICALS, INC. Business Finance Contracts & Agreements
82 Contracts & Agreements
- Financing Agreements (2 contracts)
- Note Agreements (4)
- Purchase Agreements (28)
- Registration Rights Agreements (5)
- Stock Agreements (10)
- Subscription Agreements (1)
- Underwriting Agreements (2)
- Waiver Agreements (1)
- Warrant Agreements (29)
- Form of Restricted Stock Unit Award and Form of Award Agreement (Filed With SEC on November 1, 2023)
- Registration Rights Agreement, dated as of August 10, 2023, by and between Ocuphire Pharma, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 11, 2023)
- Purchase Agreement, dated as of August 10, 2023, by and between Ocuphire Pharma, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 11, 2023)
- Form of Stock Option Grant Notice issued under the Ocuphire Pharma, Inc. 2021 Inducement Plan (Filed With SEC on March 30, 2023)
- Form of Securities Purchase Agreement, dated as of June 4, 2021, by and among Ocuphire Pharma, Inc. and the purchasers identified on the signature pages thereto (Filed With SEC on June 7, 2021)
- Form of Warrant to purchase shares of common stock (Filed With SEC on June 7, 2021)
- Form of Securities Purchase Agreement, dated as of June 4, 2021, by and among Ocuphire Pharma, Inc. and the purchasers identified on the signature pages thereto (Filed With SEC on June 4, 2021)
- Form of Warrant to purchase shares of common stock (Filed With SEC on June 4, 2021)
- Form of Waiver Agreement, dated as of February 3, 2021, by and between Ocuphire Pharma, Inc. and the Holder(s) (Filed With SEC on February 4, 2021)
- Contingent Value Rights Agreement, dated as of November 5, 2020, by and among the Company, Shareholder Representative Services LLC and the Olde Monmouth Stock Transfer Co., Inc (Filed With SEC on November 6, 2020)
- Warrant Exchange Agreement, dated September 10, 2020, by and between Rexahn Pharmaceuticals, Inc. and Empery Tax Efficient II, LP (Filed With SEC on September 11, 2020)
- Warrant Exchange Agreement, dated September 10, 2020, by and between Rexahn Pharmaceuticals, Inc. and Empery Tax Efficient, LP (Filed With SEC on September 11, 2020)
- Warrant Exchange Agreement, dated September 10, 2020, by and between Rexahn Pharmaceuticals, Inc. and Empery Asset Master, Ltd (Filed With SEC on September 11, 2020)
- Warrant Exchange Agreement, dated September 1, 2020, by and between Rexahn Pharmaceuticals, Inc. and Anson Investments Master Fund LP (Filed With SEC on September 2, 2020)
- Warrant Exchange Agreement, dated July 31, 2020, by and between Rexahn Pharmaceuticals, Inc. and Armistice Capital Master Fund Ltd (Filed With SEC on August 3, 2020)
- Note Conversion Agreement, dated as of June 8, 2020, by and among Ocuphire Pharma, Inc. and each of the purchasers party to the Amended and Restated Mezz Note Purchase Agreement (Filed With SEC on July 6, 2020)
- First Amendment to Amended and Restated Mezz Note Purchase Agreement, dated as of November 20, 2019, by and among Ocuphire Pharma, Inc. and each of the purchasers party to the... (Filed With SEC on July 6, 2020)
- Amended and Restated Mezz Note Purchase Agreement, dated as of January 22, 2019, by and among Ocuphire Pharma, Inc. and each of the purchasers set forth therein (Filed With SEC on July 6, 2020)
- Form of Financing Lock-Up Agreement, by and among Rexahn, Ocuphire, and the investors party thereto (Filed With SEC on July 1, 2020)
- Amended and Restated Securities Purchase Agreement, dated as of June 29, 2020, by and among Rexahn, Ocuphire and the investors party thereto (Filed With SEC on July 1, 2020)
- Form of Financing Lock-Up Agreement, by and among Rexahn, Ocuphire, and the investors party thereto (Filed With SEC on June 19, 2020)
- Securities Purchase Agreement, dated as of June 17, 2020, by and among Rexahn, Ocuphire and the investors party thereto (Filed With SEC on June 19, 2020)
- Registration Rights Agreement, dated June 17, 2020, by and among Rexahn and certain investors named therein (Filed With SEC on June 19, 2020)
- Description of Common Stock (Filed With SEC on February 21, 2020)
- Form of Restricted Stock Unit Agreement under the Rexahn Pharmaceuticals, Inc. 2013 Stock Option Plan (Filed With SEC on March 7, 2019)
- Form of Warrant (Filed With SEC on January 25, 2019)
- Underwriting Agreement, dated January 23, 2019, by and between Rexahn Pharmaceuticals, Inc. and Oppenheimer & Co. Inc (Filed With SEC on January 25, 2019)
- Form of Securities Purchase Agreement, dated as of October 17, 2018, by and between Rexahn Pharmaceuticals, Inc. and the purchasers signatory thereto (Filed With SEC on October 19, 2018)
- Form of Warrant (Filed With SEC on October 19, 2018)
- Form of Securities Purchase Agreement, dated as of October 13, 2017, by and between Rexahn Pharmaceuticals, Inc. and the purchasers signatory thereto (Filed With SEC on October 13, 2017)
- Form of Warrant (Filed With SEC on October 13, 2017)
- Form of Securities Purchase Agreement, dated as of June 6, 2017, by and between Rexahn Pharmaceuticals, Inc. and the investors in the offering (Filed With SEC on June 7, 2017)
- Form of Warrant (Filed With SEC on June 7, 2017)
- First Amendment to the Rexahn Pharmaceuticals, Inc. 2013 Stock Option Plan, as Amended and Restated as of June 9, 2016 (Filed With SEC on April 13, 2017)
- Form of Securities Purchase Agreement, dated as of September 14, 2016, by and between Rexahn Pharmaceuticals, Inc. and the investors in the offering (Filed With SEC on September 14, 2016)
- Form of Warrant (Filed With SEC on September 14, 2016)
- Rexahn Pharmaceuticals, Inc. 2013 Stock Option Plan, as Amended and Restated (Filed With SEC on June 10, 2016)
- Form of Stock Option Grant Agreement under Rexahn Pharmaceuticals, Inc. 2013 Stock Option Plan (Filed With SEC on March 14, 2016)
- Form of Securities Purchase Agreement, dated as of February 26, 2016, by and between Rexahn Pharmaceuticals, Inc. and the investor in the offering (Filed With SEC on February 26, 2016)
- Form of Warrant (Filed With SEC on February 26, 2016)
